PCL

본문 바로가기

팝업레이어 알림

팝업레이어 알림이 없습니다.
pcl

PRODUCT
Multi-immune source technology-based platform capable of diagnosing various diseases
COVID-19 Total Solutions
Ri02
use
·Multiple antigen diagnostic kit to detect 3 antigens for diagnosis of COVID-19 infection in human nasopharyngeal specimens​
·Influenza A, influenza B, Covid19 antigen detection​
·Automated fluorescence immunoassay applied to provide sample test results​
Performance Summary
·Multiple antigen detection in 20 minutes​
·Automated devices (6 people at a time)
·Detection limit : 103 TCID50/ml
Progress
·MFDS
·CE-IVD
·FDA EUA
How to use : Sample using swab Scan results
Negative
positive for
influenza A
positive for
influenza B
COVID-19
positive